What is Retevmo, and is it available in Latvia?
Retevmo (selpercatinib) is an oral cancer medicine used for certain RET-altered cancers. Whether it is available in Latvia depends on local reimbursement and marketing authorization timelines set by Latvia’s regulators and health system.
Because “Retevmo in Latvia” can mean different things (availability at pharmacies, hospital procurement, or whether it’s covered by the Latvian reimbursement system), the most reliable next step is to check Latvia’s medicine registry/reimbursement listings or the specific local availability notice from the Latvian side of the manufacturer/distributor.
Who sells Retevmo in Latvia?
The answer depends on the Latvian marketing authorization holder or the local distributor responsible for import and supply. These details are usually listed in Latvia’s national drug database under the exact brand name and strength.
Is Retevmo reimbursed in Latvia (and what patient paperwork is needed)?
Reimbursement rules in Latvia typically determine:
- whether patients receive it through an insured pathway,
- what diagnosis criteria are required,
- and what prior authorization steps or prescribing limits apply.
If you tell me whether you mean “patient can get it through reimbursement” or “where to buy it,” I can tailor the guidance to the right Latvian process.
What cancers is Retevmo used for (in case you’re trying to match Latvian eligibility criteria)?
Retevmo targets RET. Eligibility for coverage is often tied to specific diagnostic categories (for example, RET fusion–positive non-small cell lung cancer or RET-mutant medullary thyroid cancer), usually confirmed by approved biomarker testing. The exact coverage criteria can differ by country and reimbursement decision.
How to find the exact Latvian listing fast
Look up the brand name “Retevmo” (and, if needed, the strengths) in Latvia’s medicines database used for marketing authorization and/or reimbursement status. If you share the strength you need (for example, 40 mg, 80 mg, etc.), I can help you narrow down which listing to search.
If you want, tell me:
1) Are you asking about pharmacy availability or reimbursement?
2) Which RET indication (lung cancer, thyroid cancer, etc.)?
3) The Retevmo strength you need.
Then I can point you to the most relevant Latvian-specific check.